Company Profile
Stallergenes Greer
Company Overview
Stallergenes Greer is a fully integrated global biopharmaceutical company specializing in the diagnosis and treatment of allergies through the development and commercialization of allergy immunotherapy (AIT) products and services.
Our goal is to develop innovative allergy treatments and increase access and delivery for patients around the world. We aspire to change the treatment paradigm of allergy therapies by delivering curative medicines and innovative tools for patients.
Our business is to help alleviate the symptoms and enable the body to deal with the root causes of allergic reactions. This involves breakthroughs such as allergy immunotherapy (AIT).
Company History
The joining of Stallergenes and Greer Laboratories has united two leading AIT companies to create one, fully integrated global biopharmaceutical company with complementary strengths, consolidated expertise and collaborative innovation.